The errors at a plant in Baltimore that led to the contamination of 15 million doses of Johnson & Johnson’s COVID-19 vaccine are not expected to impact next week’s planned shipment to New Jersey, according to the state health department. But what could it mean for the months ahead? We ask Dr. Martin Blaser, director of the Center for Advanced Biotechnology and Medicine at Rutgers University.
More from this episode
Views expressed by our advertisers and sponsors are their own, and are not endorsed by NJ Spotlight News.